Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludmilla A Morozova-Roche

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Neuroimmunomodulation|September 19, 2012
Correlation between protective immunity to α-synuclein aggregates, oxidative stress and inflammationMarina A Gruden, Kiran Yanamandra, Valery G Kucheryanu, et al.
ACS Chemical Neuroscience|November 22, 2017
S100A9 Protein Aggregates Boost Hippocampal Glutamate Modifying Monoaminergic Neurochemistry: A Glutamate Antibody Sensitive Outcome on Alzheimer-like Memory DeclineMarina A Gruden, Tatiana V Davydova, Vladimir S Kudrin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 25, 2004
Formation of amyloid aggregates from human lysozyme and its disease-associated variants using hydrostatic pressureFernanda G De Felice, Marcelo N N Vieira, M Nazareth L Meirelles, et al.
FEBS Letters|April 28, 2006
Cytotoxicity of albebetin oligomers depends on cross-beta-sheet formationVladimir Zamotin, Anna Gharibyan, Natalia V Gibanova, et al.
Biochemistry|July 28, 2004
Fibrillation of carrier protein albebetin and its biologically active constructs. Multiple oligomeric intermediates and pathwaysLudmilla A Morozova-Roche, Vladimir Zamotin, Mantas Malisauskas, et al.
ACS Chemical Neuroscience|November 10, 2015
Pro-inflammatory S100A9 Protein as a Robust Biomarker Differentiating Early Stages of Cognitive Impairment in Alzheimer's DiseaseIstvan Horvath, Xueen Jia, Per Johansson, et al.
The New Phytologist|May 16, 2021
Elongation of wood fibers combines features of diffuse and tip growthMateusz Majda, Liudmila Kozlova, Alicja Banasiak, et al.
Behavioural Brain Research|February 1, 2014
Intranasal administration of alpha-synuclein aggregates: a Parkinson's disease model with behavioral and neurochemical correlatesMarina A Gruden, Tatiana V Davydova, Victor B Narkevich, et al.
Behavioural Brain Research|December 3, 2014
Noradrenergic and serotonergic neurochemistry arising from intranasal inoculation with α-synuclein aggregates which incite parkinsonian-like symptomsMarina A Gruden, Tatiana V Davydova, Victor B Narkevich, et al.
Behavioural Brain Research|March 12, 2016
The misfolded pro-inflammatory protein S100A9 disrupts memory via neurochemical remodelling instigating an Alzheimer's disease-like cognitive deficitMarina A Gruden, Tatiana V Davydova, Chao Wang, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Neuroimmunomodulation|September 19, 2012
Correlation between protective immunity to α-synuclein aggregates, oxidative stress and inflammationMarina A Gruden, Kiran Yanamandra, Valery G Kucheryanu, et al.
ACS Chemical Neuroscience|November 22, 2017
S100A9 Protein Aggregates Boost Hippocampal Glutamate Modifying Monoaminergic Neurochemistry: A Glutamate Antibody Sensitive Outcome on Alzheimer-like Memory DeclineMarina A Gruden, Tatiana V Davydova, Vladimir S Kudrin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 25, 2004
Formation of amyloid aggregates from human lysozyme and its disease-associated variants using hydrostatic pressureFernanda G De Felice, Marcelo N N Vieira, M Nazareth L Meirelles, et al.
FEBS Letters|April 28, 2006
Cytotoxicity of albebetin oligomers depends on cross-beta-sheet formationVladimir Zamotin, Anna Gharibyan, Natalia V Gibanova, et al.
Biochemistry|July 28, 2004
Fibrillation of carrier protein albebetin and its biologically active constructs. Multiple oligomeric intermediates and pathwaysLudmilla A Morozova-Roche, Vladimir Zamotin, Mantas Malisauskas, et al.
ACS Chemical Neuroscience|November 10, 2015
Pro-inflammatory S100A9 Protein as a Robust Biomarker Differentiating Early Stages of Cognitive Impairment in Alzheimer's DiseaseIstvan Horvath, Xueen Jia, Per Johansson, et al.
The New Phytologist|May 16, 2021
Elongation of wood fibers combines features of diffuse and tip growthMateusz Majda, Liudmila Kozlova, Alicja Banasiak, et al.
Behavioural Brain Research|February 1, 2014
Intranasal administration of alpha-synuclein aggregates: a Parkinson's disease model with behavioral and neurochemical correlatesMarina A Gruden, Tatiana V Davydova, Victor B Narkevich, et al.
Behavioural Brain Research|December 3, 2014
Noradrenergic and serotonergic neurochemistry arising from intranasal inoculation with α-synuclein aggregates which incite parkinsonian-like symptomsMarina A Gruden, Tatiana V Davydova, Victor B Narkevich, et al.
Behavioural Brain Research|March 12, 2016
The misfolded pro-inflammatory protein S100A9 disrupts memory via neurochemical remodelling instigating an Alzheimer's disease-like cognitive deficitMarina A Gruden, Tatiana V Davydova, Chao Wang, et al.
Pageof 8